封面
市場調查報告書
商品編碼
1728074

基因表現分析市場-全球產業規模、佔有率、趨勢、機會和預測,按產品類型、技術、應用、最終用戶、地區和競爭細分,2020 年至 2030 年

Gene Expression Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Technique, By Application, By End User, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球基因表現分析市值為 50.2 億美元,預計到 2030 年將達到 78.4 億美元,預測期內複合年成長率為 7.71%。該市場在生命科學和生物技術領域中發揮著至關重要的作用,提供分析各種生物樣本中基因表現的工具和技術。基因表現分析已成為從藥物發現和臨床診斷到個人化醫療和學術研究等應用的基礎。一個關鍵的成長因素是對個人化治療方法的需求不斷成長,其中基因表現譜有助於識別個別基因特徵,從而實現更精確、更有效的治療。技術進步,特別是 RNA-Seq 等高通量定序平台的進步,顯著增強了研究人員以前所未有的規模研究轉錄組的能力。這些技術的採用促進了生物醫學研究的激增以及製藥公司、診斷開發商和研究機構之間的合作。在腫瘤學領域,基因表現工具擴大用於發現生物標記和預測治療反應,進一步加速了市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 50.2億美元
2030年市場規模 78.4億美元
2025-2030 年複合年成長率 7.71%
成長最快的領域 RNA表達
最大的市場 北美洲

關鍵市場促進因素

定序技術的進步

主要市場挑戰

數據分析的複雜性

主要市場趨勢

單細胞RNA定序(scRNA-Seq)

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:全球基因表現分析市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型(儀器、服務、其他)
    • 依技術(RNA表現、啟動子分析、蛋白質表現及翻譯後修飾表現、其他)
    • 按應用(藥物發現和開發、臨床診斷、生物技術和微生物學、其他)
    • 按最終用戶(製藥和生物技術公司、合約研究組織 (CRO)、學術和政府研究機構等)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖
    • 依產品類型
    • 依技術
    • 按應用
    • 按最終用戶
    • 按地區

第5章:亞太基因表現分析市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章:歐洲基因表現分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第7章:北美基因表現分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章:南美基因表現分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第9章:中東和非洲基因表現分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章:市場動態

  • 驅動程式
  • 挑戰

第 11 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 12 章:全球基因表現分析市場:SWOT 分析

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章:競爭格局

  • Merck KGaA
  • Genscript Biotech Corporation
  • Qiagen
  • Bio-Rad Laboratories
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Agilent Technologies
  • Lonza Group Ltd.
  • New England Biolabs Inc

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16897

The Global Gene Expression Analysis Market was valued at USD 5.02 billion in 2024 and is projected to reach USD 7.84 billion by 2030, growing at a CAGR of 7.71% during the forecast period. This market plays a crucial role in the life sciences and biotechnology sectors, offering tools and technologies for analyzing gene expression in various biological samples. Gene expression analysis has become fundamental in applications ranging from drug discovery and clinical diagnostics to personalized medicine and academic research. A key growth factor is the rising demand for personalized treatment approaches, where gene expression profiling helps identify individual genetic signatures, enabling more precise and effective therapies. Technological advancements, particularly in high-throughput sequencing platforms like RNA-Seq, have significantly enhanced researchers' ability to investigate the transcriptome at an unprecedented scale. The adoption of these technologies has fueled a surge in biomedical research and collaboration among pharmaceutical firms, diagnostic developers, and research institutions. In oncology, gene expression tools are increasingly used to discover biomarkers and predict treatment responses, further accelerating the expansion of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.02 Billion
Market Size 2030USD 7.84 Billion
CAGR 2025-20307.71%
Fastest Growing SegmentRNA Expression
Largest MarketNorth America

Key Market Drivers

Advancements in Sequencing Technologies

Technological progress in sequencing has been a critical driver of the Global Gene Expression Analysis Market. Next-generation sequencing (NGS), in particular, has transformed gene expression studies by offering high-throughput capabilities, greater sensitivity, and cost efficiency. NGS enables the simultaneous examination of thousands of genes across numerous samples, providing deeper insights into gene activity and regulation. These capabilities have broadened the use of gene expression profiling in personalized medicine, disease diagnostics, and fundamental research. The launch of high-capacity sequencers like Illumina's NovaSeq X Series, which can process over 20,000 whole genomes annually, exemplifies how enhanced throughput and reduced costs are making transcriptome analysis more accessible and widespread. This technological evolution is reshaping genomic research and reinforcing the market's long-term growth trajectory.

Key Market Challenges

Data Analysis Complexities

One of the significant hurdles in the Global Gene Expression Analysis Market is the complexity involved in managing and interpreting large-scale gene expression data. High-throughput methods, such as RNA-Seq, generate vast volumes of data that require sophisticated bioinformatics tools and computational infrastructure for effective analysis. The necessity for robust data processing pipelines-from quality control and alignment to normalization and differential expression analysis-adds layers of technical difficulty. Missteps at any stage can lead to inaccurate conclusions, undermining research validity. Additionally, the requirement for high-performance computing resources and specialized data analytics expertise presents a cost and skill barrier for many institutions, especially smaller laboratories and emerging markets. Addressing these analytical challenges is vital for maximizing the utility and reliability of gene expression studies.

Key Market Trends

Single-Cell RNA Sequencing (scRNA-Seq)

A prominent trend in the Global Gene Expression Analysis Market is the growing use of Single-Cell RNA Sequencing (scRNA-Seq). This cutting-edge technique enables researchers to profile gene expression at the individual cell level, revealing cellular heterogeneity that is otherwise masked in bulk RNA analyses. scRNA-Seq is transforming areas such as cancer biology, immunology, neuroscience, and developmental biology by allowing precise characterization of rare cell types and cellular states. This capability is driving a deeper understanding of disease mechanisms, progression, and treatment resistance. The rise of scRNA-Seq reflects a broader shift toward high-resolution, data-rich research tools that support more accurate and personalized scientific discoveries.

Key Market Players

  • Merck KGaA
  • Genscript Biotech Corporation
  • Qiagen
  • Bio-Rad Laboratories
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Agilent Technologies
  • Lonza Group Ltd.
  • New England Biolabs Inc

Report Scope:

In this report, the Global Gene Expression Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Analysis Market, By Product Type:

  • Instruments
  • Services
  • Others

Gene Expression Analysis Market, By Technique:

  • RNA Expression
  • Promotor Analysis
  • Protein Expression & Post Translational Modification Expression
  • Others

Gene Expression Analysis Market, By Application:

  • Drug Discovery and Development
  • Clinical Diagnostics
  • Biotechnology and Microbiology
  • Others

Gene Expression Analysis Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Government Research Institutes
  • Others

Gene Expression Analysis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Expression Analysis Market.

Available Customizations:

Global Gene Expression Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Gene Expression Analysis Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product Type (Instruments, Services, Others)
    • 4.2.2. By Technique (RNA Expression, Promotor Analysis, Protein Expression & Post Translational Modification Expression, Others)
    • 4.2.3. By Application (Drug Discovery and Development, Clinical Diagnostics, Biotechnology and Microbiology, Others)
    • 4.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others)
    • 4.2.5. By Region
    • 4.2.6. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Product Type
    • 4.3.2. By Technique
    • 4.3.3. By Application
    • 4.3.4. By End User
    • 4.3.5. By Region

5. Asia Pacific Gene Expression Analysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By Technique
    • 5.2.3. By Application
    • 5.2.4. By End User
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Gene Expression Analysis Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product Type
        • 5.3.1.2.2. By Technique
        • 5.3.1.2.3. By Application
        • 5.3.1.2.4. By End User
    • 5.3.2. India Gene Expression Analysis Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product Type
        • 5.3.2.2.2. By Technique
        • 5.3.2.2.3. By Application
        • 5.3.2.2.4. By End User
    • 5.3.3. Australia Gene Expression Analysis Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product Type
        • 5.3.3.2.2. By Technique
        • 5.3.3.2.3. By Application
        • 5.3.3.2.4. By End User
    • 5.3.4. Japan Gene Expression Analysis Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product Type
        • 5.3.4.2.2. By Technique
        • 5.3.4.2.3. By Application
        • 5.3.4.2.4. By End User
    • 5.3.5. South Korea Gene Expression Analysis Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product Type
        • 5.3.5.2.2. By Technique
        • 5.3.5.2.3. By Application
        • 5.3.5.2.4. By End User

6. Europe Gene Expression Analysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Gene Expression Analysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Germany Gene Expression Analysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Spain Gene Expression Analysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User
    • 6.3.4. Italy Gene Expression Analysis Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By Technique
        • 6.3.4.2.3. By Application
        • 6.3.4.2.4. By End User
    • 6.3.5. United Kingdom Gene Expression Analysis Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By Technique
        • 6.3.5.2.3. By Application
        • 6.3.5.2.4. By End User

7. North America Gene Expression Analysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Gene Expression Analysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Gene Expression Analysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Gene Expression Analysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. South America Gene Expression Analysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Gene Expression Analysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Argentina Gene Expression Analysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Colombia Gene Expression Analysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User

9. Middle East and Africa Gene Expression Analysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 5.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Gene Expression Analysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Saudi Arabia Gene Expression Analysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. UAE Gene Expression Analysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Gene Expression Analysis Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Merck KGaA
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Genscript Biotech Corporation
  • 14.3. Qiagen
  • 14.4. Bio-Rad Laboratories
  • 14.5. Takara Bio Inc.
  • 14.6. Thermo Fisher Scientific, Inc.
  • 14.7. Promega Corporation
  • 14.8. Agilent Technologies
  • 14.9. Lonza Group Ltd.
  • 14.10. New England Biolabs Inc

15. Strategic Recommendations

16. About Us & Disclaimer